SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
University of California, San Francisco
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
C17 Council
Memorial Sloan Kettering Cancer Center
Schrödinger, Inc.
Massachusetts General Hospital